Differential Diagnosis for Macular Rash

Primary Differential Considerations

• The Centers for Disease Control and Prevention recommends considering viral exanthems, particularly enteroviral infections, as a primary differential diagnosis for macular rash, given the distribution pattern on the trunk and extremities while sparing the palms, soles, face, and scalp 1
• The American Academy of Dermatology suggests that human herpesvirus 6 (roseola) can present with macular rash following high fever, though more common in children, it occurs in nearly 100% of the population by age 3 and can reactivate 2
• The Infectious Diseases Society of America notes that Epstein-Barr virus infection presents with maculopapular rash, particularly if the patient received antibiotics (ampicillin/amoxicillin) 1
• The Centers for Disease Control and Prevention recommends considering parvovirus B19, which presents with "slapped cheek" appearance on face but can have truncal involvement 1

Drug Hypersensitivity Reactions

• The British Journal of Pharmacology states that nonspecific drug eruptions present as fine reticular maculopapular rashes or broad, flat erythematous macules and patches 4
• The Centers for Disease Control and Prevention suggests querying specifically about recent antibiotic use, NSAIDs, anticonvulsants, or any new medications within the past 2-3 weeks 1, 5

Tickborne Rickettsial Diseases

• The Centers for Disease Control and Prevention notes that Rocky Mountain Spotted Fever (RMSF) initially presents as small blanching pink macules on extremities 2-4 days after fever onset 1
• The Centers for Disease Control and Prevention recommends considering Human Monocytic Ehrlichiosis (HME), which causes rash in only one-third of adults, varying from maculopapular to diffuse erythema, rarely involving palms/soles 1

Diagnostic Approach

• The Centers for Disease Control and Prevention recommends immediate laboratory testing, including complete blood count with differential, comprehensive metabolic panel, and acute serology for R. rickettsii, E. chaffeensis, and A. phagocytophilum if RMSF/ehrlichiosis suspected 1, 6
• The Clinical Infectious Diseases journal suggests considering skin biopsy if diagnosis remains unclear after initial evaluation, particularly to rule out drug reaction or vasculitis 7

Critical Management Decisions

• The Centers for Disease Control and Prevention recommends initiating doxycycline 100 mg twice daily immediately if fever + rash + headache + tick exposure or endemic area exposure, thrombocytopenia and/or hyponatremia present, or summer months in endemic regions 1, 6
• The Clinical Infectious Diseases journal notes that delay in treatment increases mortality significantly, and treatment must begin based on clinical suspicion, without waiting for serologic confirmation 6